Biocartis Group NV provided earnings guidance for the year 2022. For the year, the company expects to Grow product revenue by 24-36% to between EUR 50 million and EUR 55 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.29 EUR | +1.05% | -.--% | -.--% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-.--% | 29.6M | |
+73.64% | 12.42B | |
-19.88% | 7.94B | |
+2.90% | 6.17B | |
+13.65% | 5.5B | |
+40.00% | 5.01B | |
-15.25% | 4.88B | |
-19.66% | 4.2B | |
-28.70% | 2.73B | |
+48.49% | 2.27B |
- Stock Market
- Equities
- BCART Stock
- News Biocartis Group NV
- Biocartis Group NV Provides Earnings Guidance for the Year 2022